Our expert panel discussed the ethics behind payments by drug companies to doctors and the role of both in ensuring transparency

A trailblazing approach to mental health by Forestry Commission Scotland and local health boards is seeing service users go on activity-filled woodland walks

Health Innovation Manchester aims to cut the city’s high premature mortality rate while turning it into a research hub

Pharmaceutical companies opting in to a code of practice are having details of their payments to healthcare professionals made public – but does the database go far enough?

Advances in genetic testing are enabling healthcare professionals to personalise treatments for diseases and conditions including cancer, diabetes and HIV

Greater understanding of genetics and characteristics of diseases are driving the development of new medicines

With money for basic and clinical research squeezed, some health researchers – including the UK team behind a dementia drug – are trying crowdfunding

Drug development is highly resource-intensive and expensive with only one in 5,000 medicines making it to the market – this is how it works